Managing Director, RPM Ventures
Chair of the Dept. of Chemical Physiology, The Scripps Research Institute
Professor of Bioengineering, University of Washington
Principal Researcher, Microsoft Research Silicon Valley Laboratory
Co-Founder and Chairman, AutoHarvest
Member, NASA Technology Roadmap Review Steering Committee
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
President and COO, Tasktop Technologies
|
|
Eight months after its public debut, Menlo Park, CA-based Calysta Energy has announced its first partnership deal. Calysta, a synthetic biology company, will attempt to engineer a new microbe that can live off methane gas and produce raw materials for... Read more »
In this “always on” era of online products and services, there is a time-saving appeal to the product introduced today by San Diego-based SlimSurveys. It’s designed to help businesses gather feedback from customers without sucking up too much of their time.... Read more »
Google was back on the stump Tuesday, trying to convince enterprise software buyers that it really, truly cares about their business.
Amit Singh, the president of Google’s enterprise business, took the stage at the E2 conference in Boston to talk about... Read more »
One of the main goals of California’s $3 billion stem cell research agency is to draw companies into the state so they can vie for a share of the funding.
With a recently funded $32 million initiative, the California Institute for... Read more »
After the dot-com crash in 2001, the tech world needed a few years to regroup. But starting around 2004, the year Facebook was founded and Google went public, the winds of innovation in consumer- and business-facing technology began to pick up... Read more »
What happens when you bring Silicon Valley business and product-design thinking to bear on problems faced by content creators, publishers, and average citizens looking for more powerful ways to communicate? That’s the question under investigation at Matter, a San Francisco-based... Read more »
Social media analytics company Dataminr in New York announced today it raised $30 million in a funding round led by Institutional Venture Partners and Venrock.
Dataminr, founded in 2009, uses Twitter’s firehose of public tweets to analyze events happening around the... Read more »
What does an ex-Facebook tycoon with a degree in electrical engineering know about fixing the U.S. healthcare system?
Well, Chamath Palihapitiya knows that healthcare is in need of some drastic reinvention, and that to some extent, this will involve training people... Read more »
On a recent rainy summer morning, Adrian Walker, co-founder of the Detroit and now San Francisco-based startup Rippld, described how he almost threw in the towel on the fledgling team-building network he built for creative professionals.
It was December 2012,... Read more »
The mysterious Wayne Chang won’t tell me much these days, but he’s got a message for Boston-area startups: Talk about distribution.
If you’re a software startup, he says, your product is obviously important. But equally important is figuring out how to... Read more »
Pearl Therapeutics’ investors are a happy group today.
AstraZeneca (NYSE: AZN), the British pharmaceutical giant, has agreed to pay $560 million up front for all of Pearl’s stock. Pearl and its investors could ultimately make more than double that... Read more »
There are tons of travel apps out there to help you plan for everything from booking tickets to translating foreign languages to finding your way through museums. But TravelNerd offers something a little different: an app that will help improve... Read more »
Biotech is a long-term business, in a world that places more value on short-term thinking. Pharma companies often cut long-term R&D budgets, or do disastrous mega-mergers, mainly to juice their profits for a quarter or two.
But sometimes people come... Read more »
Senior executives from Tumblr and Foursquare headlined the first day of Gnip’s Big Boulder Conference on “social data” on Thursday, and while they didn’t have much to say about the news that’s put their companies in the headlines in the past... Read more »
Injecting new technology into a long-established industry is a big enough task for most new companies. So is tying your fortune to a brand-new technology application that is still finding its place in the market.
New York-based Floored must like a... Read more »
There’s change brewing in the world of coffee.
Over the last 10 years or so, an assortment of independent “third wave” coffee roasters has appeared in cities like Seattle, San Francisco, New York, Boston, Austin, and Boulder—in other words, the same... Read more »
Investing in biotechnology is a riskier bet these days. The community of life sciences venture capital firms is contracting, despite scientific advances across many fields like genomics, immunology, and diagnostics. Many promising new enterprises fail to produce marketable drugs, and even... Read more »
A year after Facebook went public in the most anticipated tech IPO of its generation, money is pouring into companies that might help the social network deliver more profits to its shareholders.
Boston-based Brand Networks is among those reaping the benefits.... Read more »
Pfizer was tripped up a couple years ago, when safety concerns emerged around the first drug ever approved that could combine the targeting ability of an antibody with a toxin to give it more tumor-killing kick. But the New York-based... Read more »
Partner, Kleiner Perkins Caufield & Byers
Co-Founder and Managing Member, Psilos Group
Partner, Venrock Ventures
President and CEO, Onyx Pharmaceuticals
Professor, J. David Gladstone Institute of Cardiovascular Disease
Director, Neurobiotics Laboratory, University of Washington
Founder, Young Inventors
Founder, MicroCHIPS
Executive Director, Center for Open Innovation, UC Berkeley
Boston · 6/19/13
9:00 am
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
